US Patent 10184000 Optimized Fc variants and methods for their generation

Is a

Patent

Patent attributes

Patent Applicant

Xencor

Current Assignee

Xencor

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

10184000

Patent Inventor Names

Stephen K. Doberstein0

Robert J. Hayes0

Sher Bahadur Karki0

Wei Dang0

Arthur J. Chirino0

Gregory Alan Lazar0

John Desjarlais0

Omid Vafa0

Date of Patent

January 22, 2019

Patent Application Number

15167832

Date Filed

May 27, 2016

Patent Citations Received

‌

US Patent 11987617 Antibodies that target HIV GP120 and methods of use

‌

US Patent 10836825 Multispecific antibodies that target HIV GP120 and CD3

‌

US Patent 10882898 Human immunodeficiency virus neutralizing antibodies

‌

US Patent 10882907 Multispecific antibodies that target HIV GP120 and CD3

‌

US Patent 11597759 Multispecific antibodies that target HIV GP120 and CD3

‌

US Patent 11655285 Human immunodeficiency virus neutralizing antibodies

Patent Primary Examiner

‌

Chun W Dahle

Patent abstract

The present invention relates to optimized Fc variants, methods for their generation, and antibodies and Fc fusions comprising optimized Fc variants.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 10184000 Optimized Fc variants and methods for their generation

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 10184000 Optimized Fc variants and methods for their generation